
A Northwestern Medicine study has revealed a key mechanism underlying the development of motor neuron diseases, offering new insights into potential treatment options, according to a study published in the Journal of Neuroscience.

New consensus-based recommendations on point-of-care ultrasound skills, instructional methods, and assessment strategies could help improve ultrasound education and training nationwide, as detailed in a recent study published in Annals of Internal Medicine.

Northwestern scientists have developed and validated AI models that accurately identify children at high risk for sepsis within 48 hours, so they can receive early preemptive care.

Northwestern Medicine investigators have uncovered new insights into the synaptic connections of subgroups of interneurons, findings that may improve the understanding of fear responses and could inform new targeted therapies for post-traumatic stress disorder (PTSD), according to a recent study.

More than 99 percent of people who went on to suffer a heart attack, stroke or heart failure already had at least one risk factor above optimal level beforehand, according to a new study.

Blood pressure measured as early as age seven can predict cardiovascular mortality decades later, according to a new Northwestern Medicine study published in JAMA.

Patients with newly diagnosed glaucoma who have less wealth or reside in rural communities are less likely to receive standard glaucoma care compared to wealthier patients, according to a recent multi-institution study published in JAMA Ophthalmology.

Distinguished biochemist Svetlana Mojsov, PhD, the Lulu Chow Wang and Robin Chemers Neustein Research Associate Professor at the Rockefeller University, New York, has been named the winner of the annual $250,000 Kimberly Prize in Biochemistry and Molecular Genetics.

Black adults in the U.S. are first hospitalized for heart failure nearly 14 years earlier than white adults, according to a new study analyzing data from more than 42,000 patients across hundreds of hospitals.

A new study has shed light on how a class of diabetes drugs may protect the kidneys — not just by lowering blood sugar, but by triggering a molecular shift that dampens inflammation, according to the study published in The Journal of Clinical Investigation.